The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often viewed as outdated and hindering innovation, https://emilieyveg820457.wikirecognition.com/2020712/cannabinoid_rescheduling_a_growth_catalyst